Skip to main content
Equibles

STATE STREET CORP

Position in NVCT — Nuvectis Pharma, Inc.

CIK 93751 BOSTON, MA
Back to NVCT Full portfolio

Position in NVCT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$4,564,361
+$3,277,193 QoQ
Shares Held
248,198
+49.1% QoQ
Ownership
0.762%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 82 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 41% Shared 0% None 59%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. NVCT ranks #220 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in NVCT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,564,361 248,198
2026-03-31 $1,287,168 166,516
2025-12-31 $1,167,728 154,666
2025-09-30 $823,030 136,716
2025-06-30 $848,435 113,579
2025-03-31 $271,117 27,750
2024-12-31 $119,020 22,000
2024-09-30 $96,237 15,300
2024-06-30 $96,849 15,300
2024-03-31 $1,060,907 129,379
2023-12-31 $986,446 118,279
2023-09-30 $1,393,692 108,122
2023-06-30 $1,680,682 105,240
2023-03-31 $175,674 13,400
2022-12-31 $87,750 11,700
2022-09-30 $82,953 11,700
2022-06-30 $131,040 11,700